AMERIPRISE FINANCIAL INC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 820027
MINNEAPOLIS, MN
Position in ADPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$41,880,692
-$196,886 QoQ
Shares Held
3,017,341
+16.5% QoQ
Ownership
1.89%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 99.4650256633241.ToString("F0")%
None 0.5349743366759011.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $3,145,181,729 across 32 Diagnostics & Research names. ADPT ranks #16 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,670,400 | $821,051,708 | |
| 2 | DHR |
Danaher Corp /De/
|
3,041,408 | $576,650,954 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,624,321 | $277,011,701 | |
| 4 | WAT |
Waters Corp /De/
|
695,644 | $207,162,780 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
1,109,387 | $191,369,256 | |
| 6 | DGX |
Quest Diagnostics Inc
|
807,477 | $158,249,338 | |
| 7 | ILMN |
Illumina, Inc.
|
1,155,973 | $142,485,227 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,204,289 | $137,264,856 |
All Filings in ADPT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,880,692 | 3,017,341 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $42,077,578 | 2,590,984 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $89,336,720 | 5,971,706 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $37,746,673 | 3,240,058 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $49,353,595 | 6,642,476 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,416,636 | 736,720 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $421,944 | 82,411 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $184,290 | 50,909 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,716,875 | 846,379 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $269,176 | 54,934 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $433,923 | 79,619 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $351,985 | 52,457 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,778,921 | 427,964 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $2,818,395 | 368,900 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $9,000,887 | 648,479 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $16,282,488 | 580,274 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,731,193 | 580,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,781,729 | 533,082 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $34,343,067 | 853,032 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $44,675,197 | 755,542 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $28,760,170 | 591,408 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $16,696,711 | 345,116 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,241,599 | 332,671 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||